Apo-Imatinib 100 mg

APO-IMATINIB 100 MG tablets are a pharmaceutical product containing imatinib mesylate, used for targeted therapeutic purposes. This oral medication is manufactured by Apotex Inc. in Canada.

APO-IMATINIB 100 MG tablets are commonly used in therapeutic regimens where imatinib mesylate is indicated. Imatinib mesylate is a type of medication often utilized in the management of certain conditions that respond to targeted therapy. Patients and healthcare providers typically determine the specific uses of APO-IMATINIB 100 MG based on individual health needs and professional guidance.

APO-IMATINIB 100 MG tablets may cause various effects, which can differ among individuals. Commonly reported effects include gastrointestinal discomfort, fatigue, and skin reactions. It is important to monitor for any unusual symptoms and consult a healthcare provider if concerns arise.

Handling APO-IMATINIB 100 MG tablets requires attention to storage and administration guidelines. Store the medication as directed, typically at room temperature, and keep it out of reach of children. Follow the prescribed regimen and avoid altering the dosage without professional advice.

APO-IMATINIB 100 MG tablets may interact with certain substances, including other medications, supplements, and foods. It is advisable to inform healthcare providers about all current medications to avoid potential interactions. Alcohol and specific dietary components may also influence the effectiveness of imatinib mesylate.